Drugs / Platelet rich plasma (PRP) with exosomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04849429 | Sep 2021 → Jun 2022 | chronic pain syndrome, intervertebral disk degenerative disorder | Dr. Himanshu Bansal Foundation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet rich plasma (PRP) with exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04849429 ↗ |
| Known as | PRPex | “A Randomized, Double-blind Controlled Trial of the Efficacy of an Intra-discal Injection of Autologous Platelet-rich Plasma (PRP) Enriched With Exosomes (PRPex) Versus Placebo...” NCT04849429 ↗ |
| Route | Other | “intradiscal injection of PRP with exosomes” NCT04849429 ↗ |